Times change. The days of drug chemistry are ending at Pfizer and the days of biologicals are dawning. The Chief Chemist who helped develop Lipitor with an estimated $13 billion in sales this year is being laid off by a company headed by an attorney who just joined Pfizer a few years ago. Life isn't necessarily fair. http://online.wsj.com/article/SB119733600536720234.html?mod=hps_us_pageone
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.